Background The highest number of COVID-19 cases in Italy have been reported in
Lombardy, a region in northern Italy. We aimed to analyse the course of severe acute …

Italy was one of the first countries significantly affected by the coronavirus disease 2019
(COVID-19) epidemic. The Italian Society for Rheumatology promptly launched a …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

Background Over the month of April, Spain has become the European country with more
confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of …

Objective To investigate differences in manifestations and outcomes of coronavirus disease
2019 (COVID-19) infection between those with and without rheumatic disease. Methods We …

Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

3Rheumatology Unit, Department of Medicine, University of Perugia; 4Haematology Unit,
Department of Clinical and Experimental Medicine, University of Pisa; 5University of Pisa …

After its emergence in December 2019 in Wuhan, China, the COVID-19 outbreak has now
one of its main epicentres in Lombardy (Italy), with more than 50 000 confirmed cases and …

Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease …

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with …